Clare Balendran

Clare Balendran is an experienced professional in the field of Precision Medicine, Biomarkers, and Diagnostics. Clare has held various leadership roles in companies such as Novo Nordisk and AstraZeneca, where Clare led the strategic development and implementation of biomarker, personalized healthcare, and diagnostics in clinical projects. With a background in Cancer Cell Signaling and Molecular Cell Biology, Clare has a strong expertise in areas such as Cardiovascular Disease, Oncology, and Cell Signaling. Clare has also contributed to new target discovery for cancer therapy and investigated nuclear hormone receptors as drug targets. Clare's career spans over two decades, demonstrating their commitment to advancing personalized healthcare and precision medicine.